ATE296113T1 - Zielgerichtete abgabe von biologische-aktive medien - Google Patents

Zielgerichtete abgabe von biologische-aktive medien

Info

Publication number
ATE296113T1
ATE296113T1 AT99900624T AT99900624T ATE296113T1 AT E296113 T1 ATE296113 T1 AT E296113T1 AT 99900624 T AT99900624 T AT 99900624T AT 99900624 T AT99900624 T AT 99900624T AT E296113 T1 ATE296113 T1 AT E296113T1
Authority
AT
Austria
Prior art keywords
gas
filled
formulations
site
substances
Prior art date
Application number
AT99900624T
Other languages
English (en)
Inventor
Michel Schneider
Feng Yan
Agnes Hiver
Original Assignee
Bracco Research Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Research Sa filed Critical Bracco Research Sa
Application granted granted Critical
Publication of ATE296113T1 publication Critical patent/ATE296113T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/829—Liposomes, e.g. encapsulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99900624T 1998-02-09 1999-02-02 Zielgerichtete abgabe von biologische-aktive medien ATE296113T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810095 1998-02-09
PCT/IB1999/000182 WO1999039738A1 (en) 1998-02-09 1999-02-02 Targeted delivery of biologically active media

Publications (1)

Publication Number Publication Date
ATE296113T1 true ATE296113T1 (de) 2005-06-15

Family

ID=8235927

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99900624T ATE296113T1 (de) 1998-02-09 1999-02-02 Zielgerichtete abgabe von biologische-aktive medien

Country Status (11)

Country Link
US (1) US6258378B1 (de)
EP (1) EP1056473B8 (de)
JP (1) JP4772958B2 (de)
AT (1) ATE296113T1 (de)
AU (1) AU753196B2 (de)
CA (1) CA2319433C (de)
DE (1) DE69925461T2 (de)
ES (1) ES2244169T3 (de)
NZ (1) NZ506051A (de)
WO (1) WO1999039738A1 (de)
ZA (1) ZA99987B (de)

Families Citing this family (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US6582392B1 (en) 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) * 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
DE19913699A1 (de) 1999-03-26 2000-09-28 Basf Ag Verfahren zur Herstellung von 3,4-Dihydroprolinen und 3,4-Dehydropiperidinen
US6334859B1 (en) 1999-07-26 2002-01-01 Zuli Holdings Ltd. Subcutaneous apparatus and subcutaneous method for treating bodily tissues with electricity or medicaments
US7790144B2 (en) * 2000-01-18 2010-09-07 Mallinckrodt Inc. Receptor-avid exogenous optical contrast and therapeutic agents
US6939532B2 (en) * 2000-01-18 2005-09-06 Mallinckrodt, Inc. Versatile hydrophilic dyes
US7230088B2 (en) * 2001-07-03 2007-06-12 Mallinckrodt, Inc. Compounds for dual photodiagnosis and therapy
US20080233050A1 (en) * 2000-01-18 2008-09-25 Mallinckrodt Inc. Diagnostic and therapeutic optical agents
AU2001258117A1 (en) * 2000-05-08 2001-11-20 The University Of British Columbia Supports for photosensitizer formulations
US6656451B1 (en) * 2000-10-16 2003-12-02 Mallinckrodt, Inc. Indole compounds as novel dyes for organ function monitoring
US6669926B1 (en) 2000-10-16 2003-12-30 Mallinckrodt, Inc. Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients
US6673334B1 (en) * 2000-10-16 2004-01-06 Mallinkcrodt, Inc. Light sensitive compounds for instant determination of organ function
JP2004525916A (ja) * 2001-03-08 2004-08-26 ターゲサム・インコーポレーテッド 安定化された治療剤および撮像剤
GB0118517D0 (en) * 2001-07-30 2001-09-19 Mitsubishi Tokyo Pharm Inc Compound
JP2005504756A (ja) * 2001-08-08 2005-02-17 マリア・アントニア・ガルシア−オルメド・ドミンゲス 注射可能な泡製剤および新規な医薬的適用
US20150037402A1 (en) * 2001-08-13 2015-02-05 Lipella Pharmaceuticals, Inc. Methods and Compositions for Treating Gastric Disorders
US20130071466A1 (en) * 2001-08-13 2013-03-21 Lipella Pharmaceuticals Inc. Methods and compositions for treating gastric disorders
EP1416974A1 (de) * 2001-08-16 2004-05-12 Bristol-Myers Squibb Pharma Company Gasgefüllte mikrosphären liposome komposite
US20060057192A1 (en) * 2001-09-28 2006-03-16 Kane Patrick D Localized non-invasive biological modulation system
ATE319378T1 (de) 2001-12-03 2006-03-15 Ekos Corp Katheter mit mehreren ultraschall-abstrahlenden teilen
US7141044B2 (en) 2001-12-11 2006-11-28 Ekos Corporation Alternate site gene therapy
JP3816809B2 (ja) * 2002-01-30 2006-08-30 株式会社日立製作所 薬剤、薬剤キャリア、薬剤の製造方法及び腫瘍の治療方法
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
AU2003278807A1 (en) 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
JP2006514915A (ja) 2002-03-01 2006-05-18 ダイアックス、コープ Ｋｄｒおよびｖｅｇｆ／ｋｄｒ結合ペプチドならびに診断および治療におけるその使用
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
AU2003241598B2 (en) * 2002-07-02 2009-11-05 Nanotx Corp. Radiolabeled compounds and liposomes and their methods of making and using the same
WO2004023981A2 (en) * 2002-09-11 2004-03-25 Duke University Methods and compositions for blood pool identification, drug distribution quantification and drug release verification
US7769423B2 (en) * 2002-09-11 2010-08-03 Duke University MRI imageable liposomes for the evaluation of treatment efficacy, thermal distribution, and demonstration of dose painting
US9364569B2 (en) 2003-02-04 2016-06-14 Bracco Suisse S.A. Ultrasound contrast agents and process for the preparation thereof
US20070128117A1 (en) * 2003-02-04 2007-06-07 Bracco International B.V. Ultrasound contrast agents and process for the preparation thereof
WO2004071498A1 (en) * 2003-02-12 2004-08-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of p-glycoprotein inhibitor surfactants at the surface of a colloidal carrier
DK2284180T3 (en) 2003-03-03 2015-12-21 Dyax Corp Uses of peptides that specifically bind to the HGF receptor (cMET)
US7338796B1 (en) * 2003-08-13 2008-03-04 Sandia Corporation Vesicle-based method and apparatus for collecting, manipulating, and chemically processing trace macromolecular species
EP1694298B1 (de) * 2003-11-03 2010-06-09 Yissum Research Development Company, of The Hebrew University of Jerusalem Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set
CA2547024C (en) * 2003-12-22 2013-12-17 Bracco Research Sa Gas-filled microvesicle assembly for contrast imaging
WO2005063306A1 (en) * 2003-12-22 2005-07-14 Bracco Research Sa Assembly of gas-filled microvesicle with active component for contrast imaging
US7341569B2 (en) 2004-01-30 2008-03-11 Ekos Corporation Treatment of vascular occlusions using ultrasonic energy and microbubbles
US8012457B2 (en) * 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
CN101005858A (zh) * 2004-08-18 2007-07-25 伯拉考开发股份有限公司 用于反差成像的充气微泡组合物
AU2005307265A1 (en) * 2004-11-22 2006-05-26 Oxygenix Co., Ltd. Reagent containing oxygen isotope-labeled hemoglobin for examining vital tissue and method of producing the same
US8664392B2 (en) 2004-12-23 2014-03-04 Medibeacon, LLC Pyrazine derivatives for bioconjugation
US8153435B1 (en) 2005-03-30 2012-04-10 Tracer Detection Technology Corp. Methods and articles for identifying objects using encapsulated perfluorocarbon tracers
JP4911915B2 (ja) * 2005-05-09 2012-04-04 トヨタ自動車株式会社 標的物の分解方法及び分解装置
AU2005332157A1 (en) * 2005-05-23 2006-11-30 Mebiopharm Co., Ltd., Method of producing liposomes containing gas enclosed therein
US20070004973A1 (en) * 2005-06-15 2007-01-04 Tan Sharon M L Tissue treatment methods
US20070026024A1 (en) * 2005-07-27 2007-02-01 Drees Thomas C Compositions and methods for emulsifying a pefluorocarbon with an oxygen-carrying surfactant
US9358033B2 (en) 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US9011473B2 (en) 2005-09-07 2015-04-21 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
US8518069B2 (en) 2005-09-07 2013-08-27 Cabochon Aesthetics, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
DE102005063375A1 (de) * 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
US8257338B2 (en) * 2006-10-27 2012-09-04 Artenga, Inc. Medical microbubble generation
US9248317B2 (en) 2005-12-02 2016-02-02 Ulthera, Inc. Devices and methods for selectively lysing cells
US7885793B2 (en) 2007-05-22 2011-02-08 International Business Machines Corporation Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
US20080200863A1 (en) * 2005-12-02 2008-08-21 Cabochon Aesthetics, Inc. Devices and methods for selectively lysing cells
US20070184085A1 (en) * 2006-02-03 2007-08-09 Boston Scientific Scimed, Inc. Ultrasound activated medical device
EP2001893A2 (de) * 2006-03-02 2008-12-17 Mallinckrodt, Inc. Thiadiazolverbindungen und ihre verwendung in der lichttherapie
US20100022449A1 (en) * 2006-03-09 2010-01-28 Mallinckrodt Inc. Receptor-avid exogenous optical contrast and therapeutic agents
CN101400658A (zh) * 2006-03-10 2009-04-01 马林克罗特公司 光活性化合物和组合物及其用途
US20070265560A1 (en) 2006-04-24 2007-11-15 Ekos Corporation Ultrasound Therapy System
US20080089928A1 (en) * 2006-06-13 2008-04-17 Stavroula Sofou Liposome drug carriers with ph-sensitivity
CA2628661A1 (en) 2006-06-22 2007-12-27 Mallinckrodt Inc. Pyrazine derivatives and uses thereof in renal monitoring
US9446156B2 (en) 2006-09-05 2016-09-20 Bracco Suisse S.A. Gas-filled microvesicles with polymer-modified lipids
US9456983B1 (en) 2006-12-08 2016-10-04 Advanced Cardiovascular Systems, Inc. Therapeutic composition with enhanced vessel targeting
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
US9493817B2 (en) * 2007-03-05 2016-11-15 Genesis Research Institute, Inc. Decomposition method and decomposition apparatus for nucleic acid polymer
US8372427B2 (en) 2007-03-05 2013-02-12 Abbott Cardiovascular Systems Inc. Therapeutic composition with enhanced endothelium targeting
US9044385B2 (en) * 2007-05-16 2015-06-02 Abbott Cardiovascular Systems Inc. Therapeutic compositions for targeted vessel delivery
EP2494932B1 (de) 2007-06-22 2020-05-20 Ekos Corporation Vorrichtung zur Behandlung von intrakranialen Blutungen
US20090047318A1 (en) 2007-08-16 2009-02-19 Abbott Cardiovascular Systems Inc. Nanoparticle-coated medical devices and formulations for treating vascular disease
US8439940B2 (en) 2010-12-22 2013-05-14 Cabochon Aesthetics, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
US8709472B1 (en) 2007-11-13 2014-04-29 Abbott Cardiovascular Systems Inc. Bioactive agent-loaded heart-targeting nanoparticles
JP2011506432A (ja) * 2007-12-10 2011-03-03 エピターゲット・アーエス 非ラメラ形成脂質を含む音響感受性薬物送達粒子
EP2240176A2 (de) * 2008-01-03 2010-10-20 Do-Coop Technologies Ltd Zusammensetzungen und verfahren zur verstärkung der aktivität von podophyllotoxin
US20110196231A1 (en) * 2008-09-29 2011-08-11 Raghavan Rajagopalan Fused Ring Thiophene Dyes for Imaging and Therapy
EP2350205A2 (de) * 2008-09-29 2011-08-03 Mallinckrodt Inc. Dithienofuranfarbstoffe für bildgebung und therapie
WO2010037069A2 (en) * 2008-09-29 2010-04-01 Mallinckrodt Inc. Dithienopyrrole dyes for imaging and therapy
US9192685B2 (en) 2008-10-07 2015-11-24 Bracco Suisse S.A. Targeting construct comprising anti-polymer antibody and contrast/therapeutic agents binding to the same
EP2376459B1 (de) 2008-12-17 2015-02-18 MediBeacon, LLC Modifizierte pyrazinderivate und anwendungen davon
US8628751B2 (en) 2009-04-16 2014-01-14 Medi Beacon Development, LLC Pyrazine derivatives for optical imaging and therapy
JP5491067B2 (ja) * 2009-05-08 2014-05-14 一雄 丸山 リポソーム、リポソームの製造方法、及び医薬組成物
US8731655B2 (en) 2009-05-12 2014-05-20 Mallinckrodt Llc Compounds containing acyclic N-N bonds for phototherapy
US9186349B2 (en) 2009-05-12 2015-11-17 Mallinckrodt Llc Diaza heterocyclic compounds for phototherapy
EP2253308A1 (de) 2009-05-22 2010-11-24 Ludwig-Maximilians-Universität München Pharmazeutische Zusammensetzung mit Mikrobläschen zur gezielten Tumorbehandlung
WO2011009020A2 (en) 2009-07-16 2011-01-20 Mallinckrodt Inc. Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
WO2011031955A2 (en) 2009-09-11 2011-03-17 Mallinckrodt Inc. Optical monitoring of leukemia
EP2305216A1 (de) 2009-09-25 2011-04-06 Koninklijke Philips Electronics N.V. Zweistufen-Ultraschallprotokoll zur Arzneimittelabgabe
WO2011060113A1 (en) 2009-11-11 2011-05-19 Mallinckrodt Inc. Sulfenamide compounds for phototherapy
WO2011084571A2 (en) 2009-12-16 2011-07-14 Mallinckrodt Inc. Azide derivatives for phototherapy
EP2512588A4 (de) * 2009-12-16 2014-06-04 Univ Columbia Verfahren, vorrichtungen und systeme für ultraschallausgelöste on-demand-wirkstofffreisetzung
EP2363136A1 (de) 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Von Erwachsenenstammzellen abgeleitete Mikrovesikel zur Verwendung bei der therapeutischen Behandlung von Tumorkrankheiten
WO2012119781A2 (en) 2011-03-10 2012-09-13 University Of Geneva Novel lipids, phospholipids, phospholipid and lipid compositions and their use
WO2013039851A1 (en) 2011-09-12 2013-03-21 Mallinckrodt Llc Optical agents for imaging and visualization of matrix metalloproteinase enzymes
JP2012246306A (ja) * 2012-08-22 2012-12-13 Btg Internatl Ltd 注射可能な泡製剤および新規な医薬的適用
JP6313329B2 (ja) 2012-12-21 2018-04-18 ブラッコ・スイス・ソシエテ・アノニムＢｒａｃｃｏ Ｓｕｉｓｓｅ ＳＡ ガス封入マイクロベシクル
US11446241B2 (en) 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
US10709135B2 (en) 2013-07-29 2020-07-14 Attillaps Holdings Organophosphates for treating afflictions of the skin
DK3049117T3 (da) * 2013-09-27 2022-10-31 Exact Therapeutics As Ultralydsmedieret afgivelse af lægemidler
ES2952675T3 (es) 2013-10-22 2023-11-03 Lipella Pharmaceuticals Inc Administración de agentes mediante el uso de liposomas metaestables
KR20150062652A (ko) 2013-11-29 2015-06-08 삼성전자주식회사 초음파 감응성 리포좀, 그를 포함한 약제학적 조성물 및 그를 이용하여 개체의 체내에 활성제를 전달하는 방법
EP3157534B1 (de) 2014-06-19 2022-07-06 Attillaps Holdings Acetylcholinesterasehemmer zur behandlung von dermatologischen zuständen
JP6728186B2 (ja) 2014-12-31 2020-07-22 ランセウス メディカル イメージング， インコーポレイテッド 脂質カプセル化ガスマイクロスフェア組成物および関連方法
US10656025B2 (en) 2015-06-10 2020-05-19 Ekos Corporation Ultrasound catheter
WO2017078839A1 (en) 2015-11-02 2017-05-11 Bioatla, Llc Conditionally active polypeptides
US20170319718A1 (en) 2016-05-04 2017-11-09 Lantheus Medical Imaging, Inc. Methods and devices for preparation of ultrasound contrast agents
US9789210B1 (en) 2016-07-06 2017-10-17 Lantheus Medical Imaging, Inc. Methods for making ultrasound contrast agents
US10849924B2 (en) 2017-09-26 2020-12-01 New York Medical College Compositions and methods for restoring endothelial glycocalyx
WO2019118458A1 (en) * 2017-12-11 2019-06-20 Respirogen, Inc. Devices and methods for delivery of oxygen to a wound
MX2023003104A (es) 2020-09-16 2023-06-22 Aviceda Therapeutics Inc Agentes terapéuticos decorados con ligando de ácido siálico.
EP4457235A1 (de) 2021-12-31 2024-11-06 Aviceda Therapeutics, Inc. Glycomimetische liganden
CN115025219B (zh) * 2022-06-10 2023-07-04 上海工程技术大学 一种超声响应尿激酶溶栓纳米脂质体及其制备与应用
WO2024215999A1 (en) 2023-04-14 2024-10-17 Aviceda Therapeutics, Inc. Polysialic acid-polymer conjugate and nanoparticle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5773024A (en) 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
JPH09502191A (ja) * 1993-09-09 1997-03-04 シエーリング アクチエンゲゼルシヤフト 作用物質およびガスを含有する微粒子
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition

Also Published As

Publication number Publication date
JP2002502829A (ja) 2002-01-29
CA2319433A1 (en) 1999-08-12
CA2319433C (en) 2008-04-22
EP1056473B8 (de) 2005-07-20
EP1056473A1 (de) 2000-12-06
JP4772958B2 (ja) 2011-09-14
DE69925461T2 (de) 2006-04-27
US6258378B1 (en) 2001-07-10
AU1980999A (en) 1999-08-23
ZA99987B (en) 1999-08-06
AU753196B2 (en) 2002-10-10
WO1999039738A1 (en) 1999-08-12
EP1056473B1 (de) 2005-05-25
DE69925461D1 (de) 2005-06-30
ES2244169T3 (es) 2005-12-01
NZ506051A (en) 2003-08-29

Similar Documents

Publication Publication Date Title
ATE296113T1 (de) Zielgerichtete abgabe von biologische-aktive medien
US6484052B1 (en) Optically generated ultrasound for enhanced drug delivery
Escobar-Chavez et al. The use of sonophoresis in the administration of drugs throughout the skin
Zhao et al. Potential and problems in ultrasound-responsive drug delivery systems
Merino et al. Ultrasound‐enhanced transdermal transport
Tachibana et al. Application of ultrasound energy as a new drug delivery system
ES2284481T3 (es) Herramientas y dispositivos medicos con una visibilidad por ultrasonidos mejorada.
EP1304966B1 (de) System zum verbesserten chemischen entfernen von nekrotischem gewebe
DE60111068D1 (de) Polymere verabreichungsform von leuprolid mit verbesserter wirksamkeit
US20030233085A1 (en) Optimization of transcutaneous active permeation of compounds through the synergistic use of ultrasonically generated mechanical abrasion of the skin, chemical enhancers and simultaneous application of sonophoresis, iontophoresis, electroporation, mechanical vibrations and magnetophoresis through single application devices
ATE172625T1 (de) Verfahren zur lokalen therapeutischen erhitzung von biologischen geweben und flüssigkeiten mittels gasgefüllter liposome
ATE270121T1 (de) Automatische flüssigkeitsinjektionsvorrichtung
EA200101206A1 (ru) Применение биоразлагаемых микросфер, высвобождающих противораковый агент, для лечения глиобластомы
BR0008397A (pt) Processos para acentuar a absorção celular de uma substância suprida para dentro de uma região alvo do corpo de um paciente, para acentuar a transfecção de dna suprido para dentro de uma região alvo do corpo de um paciente, e para inibir hiperplasia ìntima vascular, sistema de suprimento de energia de ultra-som de campo uniforme e feixe largo, conjuntos para acentuar a absorção celular de uma substância suprida para dentro de uma região alvo do corpo de um paciente, para acentuar a transfecção de dna suprido para dentro de uma região alvo do corpo de um paciente, e para inibir hiperplasia ìntima vascular, e, sistema de suprimento de energia de ultra-som de campo uniforme e feixe largo
WO2000069504A8 (en) Agent delivery systems
US20090112150A1 (en) Cavitation enhanced treatment through local delivery
US11793983B2 (en) Sonodynamic therapy using microbubbles and pulsed wave ultrasound methods and systems
ES2291035T3 (es) Sinergismo de efectos dinamicos y de electropermeabilizacion sobre la vitalidad celular como nuevo agente citotoxico.
JP3102655B2 (ja) 超音波制御による薬物放出製剤
Visuri et al. Optically generated ultrasound for enhanced drug delivery
Escobar-Chávez et al. Sonophoresis: A valuable physical enhancer to increase transdermal drug delivery
van Blokland Instigating and monitoring transdermal drug delivery using ultrasound-mediated cavitation
JPS5889257A (ja) 動物用灸穴針

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1056473

Country of ref document: EP